Search research articles
Contact Us
Filters
Showing results (261-270 of 448) with videos related to
Page
of 45
Sort By:
Vaccine
|
March 10, 1998
Catch-up primary vaccination with acellular pertussis vaccines in 3-4-year-old children--reactogenicity and serological response
O Wärngård, L Nilsson, C Fåhraeus, et al.
British Journal of Clinical Pharmacology
|
April 1, 1996
Lack of effect of chloroquine on the debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19) hydroxylation phenotypes
C M Masimirembwa, L L Gustafsson, M L Dahl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 7, 2010
Does the transcription factor AP-2beta have an impact on the genetic and early environmental influence on ethanol consumption?
S Oreland, L Daoura, L Gustafsson-Ericson, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1999
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo
R A Mirghani, U Hellgren, P A Westerberg, et al.
American Journal of Clinical Pathology
|
December 1, 1990
Diagnosis and localization of prostate carcinoma by fine-needle aspiration cytology and correlation with histologic whole-organ sections after radical prostatectomy
A L Hostetter, K V Pedersen, B L Gustafsson, et al.
European Journal of Clinical Pharmacology
|
April 5, 2005
Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects
Agneta Wennerholm, Annika Allqvist, Jan-Olof Svensson, et al.
Medical Toxicology and Adverse Drug Experience
|
July 1, 1989
Hexapropymate self-poisoning causes severe and long-lasting clinical symptoms
L L Gustafsson, A Berg, A Magnusson, et al.
British Journal of Clinical Pharmacology
|
August 16, 2003
Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity
Karin Hellman, Ewa Roos, Anna Osterlund, et al.
Upsala Journal of Medical Sciences
|
January 1, 1987
Positron emission tomography: an animal model of spinal distribution of drugs after intrathecal administration
P Hartvig, L L Gustafsson, K Bergström, et al.
BJGP Open
|
February 9, 2022
Experiences of patients receiving Home Care and living with polypharmacy: a qualitative interview study
Stina Mannheimer, Monica Bergqvist, Pia Bastholm-Rahmner, et al.
Page
of 45
Search research articles
Search
Showing results (261-270 of 448) with videos related to
Sort By:
Page
of 45
Vaccine
|
March 10, 1998
Catch-up primary vaccination with acellular pertussis vaccines in 3-4-year-old children--reactogenicity and serological response
O Wärngård, L Nilsson, C Fåhraeus, et al.
British Journal of Clinical Pharmacology
|
April 1, 1996
Lack of effect of chloroquine on the debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19) hydroxylation phenotypes
C M Masimirembwa, L L Gustafsson, M L Dahl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 7, 2010
Does the transcription factor AP-2beta have an impact on the genetic and early environmental influence on ethanol consumption?
S Oreland, L Daoura, L Gustafsson-Ericson, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1999
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo
R A Mirghani, U Hellgren, P A Westerberg, et al.
American Journal of Clinical Pathology
|
December 1, 1990
Diagnosis and localization of prostate carcinoma by fine-needle aspiration cytology and correlation with histologic whole-organ sections after radical prostatectomy
A L Hostetter, K V Pedersen, B L Gustafsson, et al.
European Journal of Clinical Pharmacology
|
April 5, 2005
Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects
Agneta Wennerholm, Annika Allqvist, Jan-Olof Svensson, et al.
Medical Toxicology and Adverse Drug Experience
|
July 1, 1989
Hexapropymate self-poisoning causes severe and long-lasting clinical symptoms
L L Gustafsson, A Berg, A Magnusson, et al.
British Journal of Clinical Pharmacology
|
August 16, 2003
Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity
Karin Hellman, Ewa Roos, Anna Osterlund, et al.
Upsala Journal of Medical Sciences
|
January 1, 1987
Positron emission tomography: an animal model of spinal distribution of drugs after intrathecal administration
P Hartvig, L L Gustafsson, K Bergström, et al.
BJGP Open
|
February 9, 2022
Experiences of patients receiving Home Care and living with polypharmacy: a qualitative interview study
Stina Mannheimer, Monica Bergqvist, Pia Bastholm-Rahmner, et al.
Page
of 45